The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

iShares S&P 100 Index Fund

NYSE: OEF
Last

(U.S.) $96.47

Today's change0.00 0.00%
Updated August 25 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

iShares S&P 100 Index Fund

NYSE: OEF
Last

(U.S.) $96.47

Today's change0.00 0.00%
Updated August 25 4:00 PM -4GMT. Delayed by at least 15 minutes.

iShares S&P 100 Index Fund closed at (U.S.)$96.47.

Shares have lost 0.69% over the last five days, but have gained 5.81% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $96.47
  • High--
  • Low--
  • Bid / Ask(U.S.) $95.11 / (U.S.) $98.17
  • YTD % change+5.81%
  • Volume0
  • Average volume (10-day)322,357
  • Average volume (1-month)411,133
  • Average volume (3-month)516,517
  • 52-week range(U.S.) $81.14 to (U.S.) $97.42
  • Beta0.99
  • Trailing P/E10.11×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.43
  • Dividend yield2.52%
  • Trailing EPS(U.S.) $9.54
Updated August 25 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+452.91%

Based on its net profit margin of 452.91%, iShares S&P 100 Index Fund is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

    No News Results.

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q2/2015Q4/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Sep 30, 201409/30/2014Mar 31, 201403/31/2014Sep 30, 201309/30/2013
Revenue55494548
Total other revenue--------
Total revenue55494548
Gross profit50454144
Total cost of revenue5444
Total operating expense5444
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income50454144
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax168304423281
Income after tax168304423281
Income tax, total--000
Net income168304423281
Total adjustments to net income--------
Net income before extra. items168304423281
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items168304423281
Inc. avail. to common incl. extra. items168304423281
Diluted net income168304423281
Dilution adjustment--------
Diluted weighted average shares47514552
Diluted EPS excluding extraordinary itemsvalue per share3.585.969.405.40
Dividends per sharevalue per share0.940.830.850.81
Diluted normalized EPSvalue per share3.585.969.405.40